StockData
Inhibrx Biosciences, Inc. logo

Inhibrx Biosciences, Inc. (INBX) stock

INBXNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 13, 2026Score 1/30
$68.97−5.36 (-7.21%)

Close on Nov 20, 2026Market cap $1.02BP/E –Yield –

Inhibrx Biosciences gross profit

Gross profit is revenue minus the direct cost of the goods and services sold.

No gross profit figures for Inhibrx Biosciences

Inhibrx Biosciences has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

More Inhibrx Biosciences figures

See a number that looks wrong?